ARTICLE | Company News
MorphoSys, Absynth in infectious deal
September 3, 2010 12:06 AM UTC
MorphoSys AG (Xetra:MOR) partnered with Absynth Biologics Ltd. (Sheffield, U.K.) to discover and develop antibodies against Absynth's targets associated with Staphylococcus aureus infections includin...